8-K: PMI Q3 Earnings Soar on Smoke-Free Growth, Raises 2025 EPS Outlook

Philip Morris International reported strong third-quarter 2025 results, driven by its smoke-free business, leading to an upgraded full-year adjusted diluted EPS forecast.

Summary

• Third-quarter 2025 reported diluted EPS grew 13.2% to $2.23.
• Third-quarter 2025 adjusted diluted EPS grew 17.3% to $2.24, or 13.1% excluding currency impact.
• Smoke-free business (SFB) accounted for 41% of total net revenues and over 42% of total gross profit in Q3 2025.
• SFB shipment volumes increased by 16.6%, net revenues grew 17.7% (13.9% organically), and gross profit increased 19.5% (14.8% organically) in Q3 2025.
• IQOS, PMI's heated tobacco product, strengthened its position as the second largest nicotine brand in markets where present, gaining 0.9 percentage points to reach 9.1% share of combined cigarette and HTU industry volumes.
• VEEV e-vapor shipment volumes grew 91.0% in Q3 2025 and is now available in 46 markets.
• ZYN nicotine pouch shipment volume in the U.S. grew 37% to 205 million cans in Q3 2025, with estimated Nielsen offtake growth of 39%.
• Combustible net revenues grew 4.3% (1.0% organically) in Q3 2025, fueled by high single-digit pricing, despite lower volumes.
• Marlboro achieved 10.9% category share in Q3 2025, its highest quarterly market share since the 2008 spin.
• The regular quarterly dividend was increased by 8.9% to $1.47 per share, or an annualized $5.88 per share.

Sentiment

Score: 8

Explanation: The company reported strong Q3 results, particularly driven by its smoke-free portfolio, which is outperforming the industry. The raised full-year EPS guidance and increased dividend reflect management's confidence and positive momentum. While combustible volumes are declining, the growth in smoke-free products is more than offsetting this, indicating a successful strategic transition. The only minor negative is the Americas segment performance, but overall, the outlook is very positive.

Positives

• Third-quarter 2025 adjusted diluted EPS grew 17.3% to $2.24, exceeding prior year performance.
• Smoke-free business (SFB) continues to be a strong growth driver, with 16.6% shipment volume growth, 17.7% net revenue growth (13.9% organically), and 19.5% gross profit growth (14.8% organically) in Q3 2025.
• IQOS gained 0.9 percentage points of combined cigarette and HTU industry volumes, reaching 9.1% share, and holds approximately 76% volume share of the global heat-not-burn category.
• VEEV e-vapor shipment volumes surged by 91.0%, expanding its market presence and profitability.
• U.S. ZYN nicotine pouches demonstrated remarkable growth of 37% in shipment volume and 39% in offtake growth, reinforcing its best-in-class profitability.
• Combustible business delivered robust gross profit growth of 7.7% (4.8% organically) despite lower volumes, supported by strong pricing.
• Marlboro achieved its highest quarterly market share (10.9%) since the 2008 spin.
• Full-year 2025 adjusted diluted EPS guidance was raised to a range of $7.46-$7.56, indicating strong confidence in future performance.
• The regular quarterly dividend was increased by 8.9% to $1.47 per share.

Negatives

• Combustible cigarette shipment volumes declined by 3.2% in Q3 2025 and 1.3% for the first nine months of 2025.
• The Americas segment experienced a 5.5% reported net revenue decrease (5.0% organically) and a 76.6% reported operating income decrease (43.5% organically) in Q3 2025, partly due to special promotions for ZYN in the U.S. and higher marketing costs.
• Total international industry volume for cigarettes and HTUs is estimated to decline by around 1% for the full year 2025 (excluding China and the U.S.).
• The estimated market for cigarettes and HTUs in Europe decreased by 4.8% in Q3 2025, with cigarettes decreasing by 6.3%.
• The estimated market for cigarettes and HTUs in the Americas (excluding the U.S.) decreased by 6.2% in Q3 2025.

Risks

• Excise tax increases and discriminatory tax structures.
• Increasing marketing and regulatory restrictions that could reduce competitiveness, eliminate ability to communicate with adult consumers, or ban certain products.
• Health concerns relating to the use of tobacco and other nicotine-containing products and exposure to environmental tobacco smoke.
• Litigation related to tobacco and/or nicotine use and intellectual property.
• Intense competition.
• Effects of global and individual country economic, regulatory, and political developments, natural disasters, and conflicts, including the impact and consequences of Russia's invasion of Ukraine.
• Changes in adult smoker behavior.
• Impact of natural disasters and pandemics on business.
• Lost revenues as a result of counterfeiting, contraband, and cross-border purchases.
• Governmental investigations.
• Unfavorable currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds.
• Adverse changes in applicable corporate tax laws.
• Recent and potential future tariffs imposed by the U.S. and other countries.
• Adverse changes in the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for electronic devices.
• Integrity of information systems and effectiveness of data privacy policies.
• Unsuccessful attempts to introduce, commercialize, and grow smoke-free products or if regulation or taxation do not differentiate between such products and cigarettes.
• Inability to successfully introduce new products, promote brand equity, enter new markets, or improve margins through increased prices and productivity gains.
• Inability to expand brand portfolio internally or through acquisitions and the development of strategic business relationships.
• Inability to attract and retain the best global talent, including women or diverse candidates.
• Inability to successfully integrate and realize expected benefits from recent transactions and acquisitions.
• Lower predictability of smoke-free products performance.

Future Outlook

Philip Morris International raised its full-year 2025 adjusted diluted EPS forecast to a range of $7.46-$7.56, or $7.36-$7.46 excluding currency, reflecting projected growth of 13.5%-15.1% and 12.0%-13.5% respectively, compared to 2024. The company anticipates total international industry volume for cigarettes and heated tobacco units to decline by approximately 1%, while PMI's total shipment volume is expected to grow by around 1%, driven by 12%-14% growth in smoke-free products, partly offset by a 2% decline in cigarette volumes. Organic net revenue growth is forecast at 6%-8%, with organic operating income growth of 10%-11.5%. Operating cash flow is projected to exceed $11.5 billion, with capital expenditures of approximately $1.6 billion primarily for the smoke-free business. PMI aims to improve its net debt to adjusted EBITDA ratio to around 2x by the end of 2026 and does not plan share repurchases in 2025.

Management Comments

• "In the third quarter, we continued to invest in the growth of our increasingly profitable smoke-free business, while achieving record quarterly smoke-free gross profit and adjusted diluted EPS." Jacek Olczak, CEO.
• "Our global smoke-free portfolio is outgrowing the industry by a clear margin, driving positive total volumes, strong top-line growth and impressive margin expansion." Jacek Olczak, CEO.
• "We are on track to exceed our industry-leading 2024-26 growth targets and upgrade our 2025 full-year adjusted diluted EPS forecast." Jacek Olczak, CEO.

Industry Context

The filing highlights a clear industry trend of declining combustible cigarette volumes, with PMI's cigarette volumes down 3.2% in Q3 2025 and the total international industry volume for cigarettes and HTUs expected to decline by 1% for the full year. In contrast, the smoke-free category continues its robust expansion, with PMI's smoke-free product shipment volumes growing 16.6% in Q3 2025. PMI's IQOS brand is outperforming the heat-not-burn category, holding approximately 76% volume share, and its ZYN nicotine pouches are driving significant growth in the U.S. and international markets. This performance underscores the broader industry shift towards reduced-risk products, where PMI is a leading innovator and market consolidator, actively transitioning its portfolio away from traditional tobacco.

Comparison to Industry Standards

• PMI's global smoke-free portfolio is outgrowing the industry by a clear margin.
• IQOS strengthened its position as the second largest nicotine brand in markets where present, gaining 0.9 percentage points of combined cigarette and HTU industry volumes to reach 9.1% share.
• PMI holds approximately 76% volume share of the global heat-not-burn category, indicating a dominant position.
• U.S. ZYN accelerated its offtake growth to a remarkable 39% in Q3, also driving category growth to over 40%, suggesting strong market leadership and category expansion.
• Marlboro reached 10.9% category share, its highest quarterly market share since the 2008 spin, demonstrating strong performance for a combustible brand in a declining market.
• PMI is on track to exceed its industry-leading 2024-26 growth targets, positioning it favorably against competitors.

Corporate Governance

Legal Proceedings

• The filing mentions "litigation related to tobacco and/or nicotine use and intellectual property" as a general business risk.
• A "Germany excise tax classification litigation charge" is listed as an adjusting item for EPS and operating income, but no details on the outcome or ongoing status are provided in the main text.
• An "Egypt sales tax charge" of $45 million was recorded in Q3 2024 following a ruling by the Higher Administrative Court in Egypt for tax assessments from 2014-2016, indicating a concluded adverse legal outcome.

Related Party Transactions

• The filing mentions "dividend income from our deconsolidated Canadian affiliate" (Rothmans, Benson & Hedges, Inc. RBH) as part of operating cash flow forecast assumptions.
• It also lists "RBH (Canada) Plan Implementation, including dividend income, net" as an adjusting item for EPS and operating income.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, raised EPS guidance, and an increased quarterly dividend. The strategic shift to smoke-free products is showing profitable growth, potentially increasing long-term shareholder value.
• Consumers: Expanded availability of smoke-free products (IQOS, ZYN, VEEV) in more markets offers more choices for legal-age nicotine users seeking alternatives to cigarettes. Innovation in IQOS consumables (DELIA, LEVIA) aims to attract new user cohorts.
• Employees: The evolved organizational model and new segment reporting effective January 1, 2026, may lead to internal restructuring, but the overall strategic direction towards a smoke-free company suggests a focus on growth and innovation.
• Regulatory Authorities: Continued engagement with regulatory bodies, as evidenced by FDA authorizations for Swedish Match's products and IQOS, and ongoing monitoring of excise taxes and marketing restrictions.
• Suppliers: Continued investment in the smoke-free business, with capital expenditures of approximately $1.6 billion, will likely benefit suppliers of components and materials for electronic devices.

Next Steps

• Roll out the ILUMA i device and innovate on IQOS consumables (DELIA, LEVIA).
• Broader roll-out of BONDS by IQOS in Indonesia.
• Continue building and commercializing the VEEV brand in a focused, responsible, and profitable manner.
• Further enhance the strength and presence of the ZYN brand through commercial activities and competitive price positioning.
• Implement an evolved organizational model with two primary business units (International and U.S.) effective January 1, 2026.
• Realign reportable segments to International Smoke-Free, International Combustibles, and U.S. as of Q1 2026.
• Disclose select historical financial information for 2023-2025 based on the new segments in the weeks following the 2025 full-year earnings announcement.
• Target a net debt to adjusted EBITDA ratio of around 2x by the end of 2026.
• File the Quarterly Report on Form 10-Q for the third quarter ended September 30, 2025, in the coming days.

Key Dates

Recommendation

Philip Morris International's Q3 2025 results demonstrate robust performance, significantly driven by its high-growth smoke-free portfolio. The company's ability to achieve record smoke-free gross profit and adjusted diluted EPS, coupled with a substantial increase in full-year EPS guidance, signals strong operational execution and a successful strategic pivot. The impressive market share gains for IQOS and explosive growth of ZYN and VEEV underscore PMI's leadership in the reduced-risk product category, which is outperforming the declining combustible market. The 8.9% dividend increase further reinforces financial strength and commitment to shareholder returns. Despite some regional headwinds in combustibles and increased U.S. investments, the overall trajectory is highly positive, making PMI a compelling 'strong buy' for investors seeking exposure to a transforming global consumer goods leader.

Keywords

Philip Morris International, PMI, SEC Filing, 8-K, Earnings Report, Q3 2025, Financial Results, Smoke-Free Products, IQOS, ZYN, VEEV, Heated Tobacco Units, Nicotine Pouches, E-Vapor, Combustibles, Cigarettes, EPS Guidance, Dividend, Tobacco Industry, Consumer Goods, Market Share, Organic Growth, Net Revenues, Operating Income, Risk Factors, Strategic Update, Segment Reporting